FLEXION THERAPEUTICS INC's ticker is FLXN and the CUSIP is 33938J106. A total of 104 filers reported holding FLEXION THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $6,454,000 | -5.7% | 1,058,094 | +27.3% | 0.00% | 0.0% |
Q2 2021 | $6,842,000 | -0.7% | 831,434 | +8.0% | 0.00% | 0.0% |
Q1 2021 | $6,891,000 | -15.2% | 769,975 | +9.3% | 0.00% | 0.0% |
Q4 2020 | $8,130,000 | +16.2% | 704,550 | +4.9% | 0.00% | 0.0% |
Q3 2020 | $6,994,000 | -10.1% | 671,948 | +13.6% | 0.00% | -50.0% |
Q2 2020 | $7,780,000 | +94.6% | 591,672 | +16.5% | 0.00% | +100.0% |
Q1 2020 | $3,998,000 | -79.6% | 508,040 | -46.4% | 0.00% | -50.0% |
Q4 2019 | $19,602,000 | +225.5% | 947,034 | +115.5% | 0.00% | +100.0% |
Q3 2019 | $6,023,000 | +13.2% | 439,497 | +1.6% | 0.00% | 0.0% |
Q2 2019 | $5,321,000 | +4.7% | 432,678 | +6.3% | 0.00% | 0.0% |
Q1 2019 | $5,081,000 | -41.6% | 407,174 | -47.0% | 0.00% | 0.0% |
Q4 2018 | $8,702,000 | +23.5% | 768,866 | +104.1% | 0.00% | -50.0% |
Q3 2018 | $7,046,000 | -24.6% | 376,619 | +4.1% | 0.00% | -33.3% |
Q2 2018 | $9,347,000 | +34.6% | 361,623 | +16.7% | 0.00% | +50.0% |
Q1 2018 | $6,942,000 | -8.8% | 309,786 | +1.9% | 0.00% | -33.3% |
Q4 2017 | $7,611,000 | +40.0% | 303,958 | +35.2% | 0.00% | +50.0% |
Q3 2017 | $5,436,000 | +28.0% | 224,843 | +7.1% | 0.00% | 0.0% |
Q2 2017 | $4,246,000 | -22.8% | 209,994 | +2.8% | 0.00% | 0.0% |
Q1 2017 | $5,499,000 | +54.6% | 204,357 | +9.3% | 0.00% | 0.0% |
Q4 2016 | $3,557,000 | +15.5% | 187,039 | +18.6% | 0.00% | 0.0% |
Q3 2016 | $3,079,000 | +41.6% | 157,642 | +8.4% | 0.00% | +100.0% |
Q2 2016 | $2,175,000 | +214.3% | 145,396 | +93.2% | 0.00% | – |
Q1 2016 | $692,000 | -50.7% | 75,274 | +3.2% | 0.00% | -100.0% |
Q4 2015 | $1,405,000 | +31.4% | 72,962 | +1.4% | 0.00% | 0.0% |
Q3 2015 | $1,069,000 | -26.7% | 71,959 | +8.0% | 0.00% | 0.0% |
Q2 2015 | $1,458,000 | +7.0% | 66,651 | +10.1% | 0.00% | 0.0% |
Q1 2015 | $1,363,000 | +96.7% | 60,536 | +76.3% | 0.00% | – |
Q4 2014 | $693,000 | +48.1% | 34,343 | +33.8% | 0.00% | – |
Q3 2014 | $468,000 | +63.1% | 25,664 | +20.5% | 0.00% | – |
Q2 2014 | $287,000 | -16.8% | 21,295 | +1.3% | 0.00% | – |
Q1 2014 | $345,000 | – | 21,025 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,842,578 | $40,001,000 | 7.32% |
MILLER VALUE PARTNERS, LLC | 5,274,439 | $54,907,000 | 1.97% |
Mesirow Financial Investment Management, Inc. | 32,371 | $337,000 | 1.44% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,068,580 | $11,124,000 | 1.25% |
Clearline Capital LP | 399,159 | $4,155,000 | 1.09% |
CLOUGH CAPITAL PARTNERS L P | 1,246,150 | $12,972,000 | 0.93% |
Novo Holdings A/S | 1,403,370 | $14,609,000 | 0.72% |
SNOW CAPITAL MANAGEMENT LP | 303,265 | $3,157,000 | 0.63% |
AMERICAN FINANCIAL GROUP INC | 317,700 | $3,308,000 | 0.46% |
Granahan Investment Management | 1,257,690 | $13,093,000 | 0.44% |